Stem Cells for Lyme Disease – Risks

Despite considerable hubbub and hype regarding the use of stem cells for Lyme disease, risks are also associated with the procedures and need taking into account during any decision-making process. It it the nature of medical marketing that positive stories of patients will be heavily featured in the press whilst the dozens of others seeing no sustained benefit get nary a glimpse of the limelight. The worry with overseas stem cell clinics is that patients already vulnerable will not only be exploited for their money but will also be exposed to dangerous medical procedures, side-effects that are not covered by insurance back home. Lyme disease patients undergoing experimental therapies are usually considered ineligible for participation in future clinical trials, and patients may even develop other infections due to unsanitary and unhygienic practices in overseas clinics. There is also often significant emotional hardship associated with the unfulfilled hope and promise of overseas stem cell therapy for Lyme disease.

Lyme Disease Stem Cell Therapy and Infection

Patients undertaking stem cell therapy for Lyme disease are usually recommended to ensure they are first treated with antibiotics to thoroughly eradicate Lyme and any co-infections. Persistent chronic Lyme disease symptoms are often due to undiagnosed co-infections that are not addressed with Lyme disease antibiotics. Poor screening practices can then cause patients to believe their Lyme disease remains and lead them to pursue dangerous intravenous antibiotic regimes to eradicate a non-existent infection. As stem cell therapies for Lyme disease may involve injections into the epidural space, and even into the brain itself, it is extremely important that the patient not be suffering from an acute infection for fear of that infection spreading to the central nervous system. Where stem cells are used that are not the patient’s own they may be given immunosuppressants to prevent transplant rejection. If an infection is present then this suppression of the immune system could allow it to spread.

Lyme Disease Stem Cell Therapy and Insurance

Stem cell therapy for Lyme disease usually involves more than one round of injections at an overseas clinic. Patients will have to pay for accommodation and expenses during their treatment, as well as travel, and care upon return home. As the cost of experimental stem cell treatments cannot be covered by insurance it is often out of the reach of most Lyme disease sufferers who may not have been working during their illness. It is also important to check whether any complications from the procedure that arise after returning home are covered by insurance as, oftentimes, any problems traceable to the stem cell therapy are not included in healthcare.

Read On for the Possible Benefits of Stem Cell Treatment for Lyme Disease.